Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongtao Fan

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Gut|April 1, 2022
Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patientsChao Zhang, Jiesheng Li, Yongqian Cheng, et al.
Rheumatology (Oxford, England)|February 3, 2026
Vunakizumab in patients with active psoriatic arthritis: a multicentre, randomized, double-blind, placebo-controlled, phase 2 studyYu Xue, Lingyun Sun, Ning Zhang, et al.
Cancer Cell|January 16, 2026
Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunityJianan Li, Huilan Liu, Qile Guo, et al.
Cell|March 27, 2025
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancerZedao Liu, Zhenlin Yang, Junqi Wu, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Gut|April 1, 2022
Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patientsChao Zhang, Jiesheng Li, Yongqian Cheng, et al.
Rheumatology (Oxford, England)|February 3, 2026
Vunakizumab in patients with active psoriatic arthritis: a multicentre, randomized, double-blind, placebo-controlled, phase 2 studyYu Xue, Lingyun Sun, Ning Zhang, et al.
Cancer Cell|January 16, 2026
Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunityJianan Li, Huilan Liu, Qile Guo, et al.
Cell|March 27, 2025
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancerZedao Liu, Zhenlin Yang, Junqi Wu, et al.
Pageof 6